StentCenter -- Angioplasty.Org

Home » StentCenter

Sign Up Now!
Sign up for news alerts, special features and interviews with leading interventionalists about stents and more..

Drug-Eluting Stent Overview

Drug-eluting stents (a.k.a. "coated" or "medicated" stents) were developed to solve one of the biggest problems of percutaneous interventional coronary treatment: restenosis -- reblocking or reclosure of the artery. (Read more...)

NewsCenter: Reports and Features
Breaking news, original reporting and links to research about drug-eluting stents:

•	Abbott's XIENCE V® Drug-Eluting Stent Superior to Boston Scientific's TAXUS® at One Year (Sep 23)
•	Endeavor® Stent Reduced Risk of Heart Attack/Cardiac Death by 48% at Three Years Compared to Taxus® Stent in Large Study (Sep 21)
•	Drug-Eluting Stent Summit Announced for TCT 2009 Meeting in San Francisco (Sep 15)
•	Drug-Eluting Stents: Looking Ahead (Sep 15)
•	Drug-Eluting Stents: Looking Back (Aug 22)
•	FALSE: Stents Denied to Patients Over 59 (Aug 19)
•	Medtronic Awarded $57 Million in Patent Dispute with AGA Medical Corp. (Aug 6)
•	Medtronic and Abbott Laboratories Resolve Global Vascular Patent Disputes (Jul 27)
•	Stents: An Insider's Look -- OCT and Stent Strut Coverage (July 5)
•	Endeavor Drug-Eluting Stent Is First to Receive CE Mark for Treating Acute Coronary Syndrome (May 19)
•	Medtronic's Endeavor® Drug-Eluting Coronary Stent Approved in Japan (Mar 30)
•	ZEST: 3 Stents Go Head-to-Head-to-Head (Mar 29)
•	All Drug-Eluting Stents News

Late Stent Thrombosis

Reports presented at the 2006 World Congress of Cardiology and to a special FDA panel have called attention to potential problems with drug-eluting stents. What does this mean for patients? (Read more...)

Answers to Top Ten Questions About Stents & Angioplasty vs. Drug Therapy

The COURAGE Trial was an important study, but reports about it have caused confusion for patients and physicians.
(Read more...)

With thousands of postings, Angioplasty.Org's Forum is an active patient community with discussions on drug-eluting stents, antiplatelet therapy and more.

Angioplasty.Org Interview with:
David E. Kandzari, MD

Dr. Kandzari is Director of Interventional Cardiology Research at Scripps Clinic in La Jolla, California. His career in interventional cardiology has been unique in that he has had the opportunity to be involved in drug-eluting stent issues from multiple perspectives..

Q: Where is DES usage today and has the worry about safety subsided?
Dr. Kandzari: We now have observed that the utilization of drug-eluting stents in the United States has increased to account for about 75-76% of all PCI procedures. And I think it's likely that...this 75-80% DES utilization on average will be close to approximating equilibrium, pending resolution of outstanding issues of stent safety -- including what the optimal duration of dual antiplatelet therapy is, and also with the introduction of advanced generation drug-eluting stents that might be perceived safer. I think that most clinicians, even well beyond the interventional community, feel reassured of the overall benefits of drug-eluting stent use in appropriately selected patients. . (Read entire interview...)

Also read the Angioplasty.Org Interview with: Gregg W. Stone, MD
		Dr. Stone is Director of Cardiovascular Research and Education at New York-Presbyterian Hospital / Columbia University Medical Center. He is one of the world's leading interventional cardiologists and was principal investigator for the TAXUS IV drug-eluting stent clinical trial..

External Reference Material and Bibliographic Links
A selected listing of journal articles and web links about stents and related topics. These are provided as a service by Angioplasty.Org, which is not responsible for the content found on any external sites. (Coming soon.)

Visit Medtronic's Website for More Information on Stents and Other Pioneering Therapies
Medtronic, Inc., headquartered in Minneapolis, Minnesota, is the global leader in medical technology – alleviating pain, restoring health and extending life for millions of people around the world.

Angioplasty.Org Home • PatientCenter

send comments & suggestions to "info at angioplasty dot org"
read Terms of Use and Privacy statement

Angioplasty.Org is an independent educational health site
The StentCenter on Angioplasty.Org is supported by
Medtronic, Inc.
Unless otherwise noted, all content, including text, photos and video
© Copyright Venture Digital LLC 1996-2009